Regeneron Pharmaceuticals, Inc. (REGN) Ownership

$600.00

south_east
-$0 (0%)
Day's range
$599.9
Day's range
$618.01

Regeneron Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 11/07/2025 9.05 M $5.09 B   -3.99% 8.61%
BLACKROCK, INC. 11/12/2025 8.84 M $4.97 B   -4.73% 8.41%
STATE STREET CORP 11/14/2025 4.69 M $2.64 B   -2.91% 4.46%
DODGE & COX 11/13/2025 4.55 M $2.56 B   18.94% 4.33%
JPMORGAN CHASE & CO 11/26/2025 4.07 M $2.29 B   3.37% 3.87%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 2.54 M $1.42 B   2.87% 2.41%
FRANKLIN RESOURCES INC 11/13/2025 2.45 M $1.38 B   6.04% 2.33%
CAPITAL WORLD INVESTORS 11/13/2025 2.00 M $1.12 B   1.65% 1.90%
LOOMIS SAYLES & CO L P 11/13/2025 1.98 M $1.11 B   1.98% 1.88%
FMR LLC 11/13/2025 1.94 M $1.09 B   -41.82% 1.84%
INVESCO LTD. 11/13/2025 1.48 M $834.67 M   37.98% 1.41%
MORGAN STANLEY 11/14/2025 1.45 M $815.84 M   12.68% 1.38%
NUVEEN, LLC 11/12/2025 1.18 M $660.82 M   39.66% 1.12%
BANK OF AMERICA CORP /DE/ 11/14/2025 1.15 M $648.82 M   -5.44% 1.10%
NORTHERN TRUST CORP 11/14/2025 984.79 K $553.72 M   2.74% 0.94%
GOLDMAN SACHS GROUP INC 11/14/2025 952.84 K $535.75 M   19.67% 0.91%
TWO SIGMA ADVISERS, LP 11/14/2025 926.20 K $520.77 M   -1.31% 0.88%
CAPITAL INTERNATIONAL INVESTORS 11/13/2025 876.56 K $492.85 M   -72.31% 0.83%
D. E. SHAW & CO., INC. 11/14/2025 861.59 K $484.45 M   10.82% 0.82%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2025 804.91 K $452.58 M   5.02% 0.77%
LEGAL & GENERAL GROUP PLC 11/13/2025 770.36 K $433.15 M   4.16% 0.73%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 755.57 K $424.83 M   4.90% 0.72%
UBS ASSET MANAGEMENT AMERICAS INC 11/14/2025 744.17 K $418.43 M   -13.51% 0.71%
AQR CAPITAL MANAGEMENT LLC 11/14/2025 721.35 K $405.60 M   528.67% 0.69%
DEUTSCHE BANK AG\ 11/13/2025 696.68 K $391.72 M   -1.99% 0.66%
BANK OF NEW YORK MELLON CORP 11/03/2025 671.63 K $377.64 M   2.29% 0.64%
AMERICAN CENTURY COMPANIES INC 11/12/2025 660.60 K $371.44 M   3.76% 0.63%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 658.30 K $370.14 M   -8.61% 0.63%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 624.20 K $350.97 M   13.35% 0.59%
AMUNDI 11/14/2025 621.74 K $364.02 M   -30.70% 0.59%
ACADIAN ASSET MANAGEMENT LLC 11/13/2025 584.51 K $328.59 M   25.50% 0.56%
QUBE RESEARCH & TECHNOLOGIES LTD 11/14/2025 548.73 K $308.54 M   -12.34% 0.52%
ALLIANCEBERNSTEIN L.P. 11/14/2025 523.88 K $294.56 M   -10.79% 0.50%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 499.10 K $280.62 M   -3.92% 0.47%
ASSENAGON ASSET MANAGEMENT S.A. 10/07/2025 477.81 K $268.66 M   12.87% 0.45%
BNP PARIBAS ARBITRAGE, SNC 11/13/2025 477.65 K $268.57 M   -8.91% 0.45%
TWO SIGMA INVESTMENTS, LP 11/14/2025 469.90 K $264.21 M   -5.99% 0.45%
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC 11/14/2025 462.50 K $260.05 M   115.40% 0.44%
JANE STREET GROUP, LLC 11/14/2025 445.70 K $250.60 M   471.41% 0.42%
PACER ADVISORS, INC. 10/15/2025 445.33 K $250.39 M   0.04% 0.42%
NEUBERGER BERMAN GROUP LLC 11/12/2025 415.71 K $233.74 M   2.60% 0.40%
CENTIVA CAPITAL, LP 11/14/2025 400.00 K $224.91 M   792.86% 0.38%
MARSHALL WACE, LLP 11/13/2025 386.88 K $217.53 M   61.26% 0.37%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 11/14/2025 381.02 K $214.23 M   0.39% 0.36%
TD ASSET MANAGEMENT INC 11/10/2025 374.26 K $210.44 M   15.92% 0.36%
ROYAL BANK OF CANADA 11/14/2025 373.10 K $209.78 M   -3.06% 0.36%
HSBC HOLDINGS PLC 11/13/2025 369.97 K $208.48 M   2.17% 0.35%
UBS GROUP AG 11/13/2025 339.49 K $190.88 M   15.66% 0.32%
BARCLAYS PLC 11/12/2025 325.92 K $183.26 M   -32.53% 0.31%
PICTET ASSET MANAGEMENT HOLDING SA 11/18/2025 323.37 K $181.68 M   6.33% 0.31%

Regeneron Pharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 1827 institutional investors and hedge funds held shares of Regeneron Pharmaceuticals, Inc.. The most heavily invested institutionals were:

VANGUARD GROUP INC: 9.05 M

BlackRock, Inc.: 8.84 M

STATE STREET CORP: 4.69 M

DODGE & COX: 4.55 M

JPMORGAN CHASE & CO: 4.07 M

GEODE CAPITAL MANAGEMENT, LLC: 2.54 M

82.71% of Regeneron Pharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 114.49 M shares in the last 24 months. This purchase volume represents approximately $68.70 B in transactions.